Forward-Looking Statements for NeoStem, Inc.This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's Registration Statement on Form S-4 and periodic filings made with the Securities and Exchange Commission. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control. For more information, please contact:NeoStem, Inc. Robin L. Smith, CEOPhone: +1-212-584-4174Email: firstname.lastname@example.orgWeb: http://www.neostem.com ImmunoCellular Therapeutics, Ltd.CEOcast, Inc. James Young, 212-732-4300Investor Relations email@example.com SOURCE NeoStem, Inc.; ImmunoCellular Therapeutics, Ltd.